The Asia Pacific Implantable Loop Recorders Market is expected to witness market growth of 13.2% CAGR during the forecast period (2020-2026).
The ILR is the first phase in what should be a growing area of long-term physiological monitoring devices. The development of new sensors that could be used to measure blood pressure or blood volume is expected to continue to provide details on the syncope mechanism. Continued sensor technology is expected to potentially include commercial products capable of measuring blood pressure, cholesterol, oxygen saturation, and brain function, as well as other physiological parameters.
These innovative opportunities will include better tools for tracking patients with a range of disabilities in the "real world" outpatient setting. In addition to the assumption that existing external tracking systems are capable of being activated by patients, both patients will be offered the option of an auto-triggering incident monitor with more regular symptoms of ILR reserved for more unusual symptoms. The ILR has emerged as a secure and efficient method to monitor patients suffering from chronic unexplained syncope. In addition, it is possible to track atrial fibrillation and to classify the etiology of palpitations.
Increased incidence of cardiac problems, the technical innovation of cardiac monitors, and demand for remote patient tracking are increasing the market for implantable loop recorders. In addition, physical inactivity related to a sedentary lifestyle raises the likelihood of having chronic cardiac conditions, which are anticipated to fuel the need for cardiovascular care and self-monitoring.
Based on Application, the market is segmented into Atrial fibrillation, Cardiac Arrhythmia and Cardiac syncope. Based on End User, the market is segmented into Hospitals, Cardiac Centers and Other End Users. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, Angel Medical Systems, Inc., and Vectorious Medical Technolgoies Ltd.
Scope of the Study
Market Segmentation:
By Application
By End User
By Country
Companies Profiled
Unique Offerings from the Publisher
The ILR is the first phase in what should be a growing area of long-term physiological monitoring devices. The development of new sensors that could be used to measure blood pressure or blood volume is expected to continue to provide details on the syncope mechanism. Continued sensor technology is expected to potentially include commercial products capable of measuring blood pressure, cholesterol, oxygen saturation, and brain function, as well as other physiological parameters.
These innovative opportunities will include better tools for tracking patients with a range of disabilities in the "real world" outpatient setting. In addition to the assumption that existing external tracking systems are capable of being activated by patients, both patients will be offered the option of an auto-triggering incident monitor with more regular symptoms of ILR reserved for more unusual symptoms. The ILR has emerged as a secure and efficient method to monitor patients suffering from chronic unexplained syncope. In addition, it is possible to track atrial fibrillation and to classify the etiology of palpitations.
Increased incidence of cardiac problems, the technical innovation of cardiac monitors, and demand for remote patient tracking are increasing the market for implantable loop recorders. In addition, physical inactivity related to a sedentary lifestyle raises the likelihood of having chronic cardiac conditions, which are anticipated to fuel the need for cardiovascular care and self-monitoring.
Based on Application, the market is segmented into Atrial fibrillation, Cardiac Arrhythmia and Cardiac syncope. Based on End User, the market is segmented into Hospitals, Cardiac Centers and Other End Users. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, Angel Medical Systems, Inc., and Vectorious Medical Technolgoies Ltd.
Scope of the Study
Market Segmentation:
By Application
- Atrial fibrillation
- Cardiac Arrhythmia and
- Cardiac syncope
By End User
- Hospitals
- Cardiac Centers
- Other End Users
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Companies Profiled
- Medtronic PLC
- Abbott Laboratories
- Boston Scientific Corporation
- BIOTRONIK SE & Co. KG
- Angel Medical Systems, Inc.
- Vectorious Medical Technolgoies Ltd.
Unique Offerings from the Publisher
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Asia Pacific Implantable Loop Recorders Market by Application
Chapter 4. Asia Pacific Implantable Loop Recorders Market by End-user
Chapter 5. Asia Pacific Implantable Loop Recorders Market by Country
Chapter 6. Company Profiles
Companies Mentioned
- Medtronic PLC
- Abbott Laboratories
- Boston Scientific Corporation
- BIOTRONIK SE & Co. KG
- Angel Medical Systems, Inc.
- Vectorious Medical Technologies Ltd.
Methodology
LOADING...
